Assura turi dabartinį AAQS lygį 5. Didelis AAQS gali būti vertinamas kaip teigiamas ženklas, rodantis, kad įmonė sėkmingai vystosi. Investuotojai gali tikėtis, kad įmonė yra teisingame kelyje siekiant pelno. Kita vertus, svarbu lyginti akcijos Assura AAQS su pasiektais pelnais ir kitų tos pačios pramonės šakos įmonių rodikliais. Didelis AAQS nėra absoliuti garantija teigiamai ateities perspektyvai. Tik tokiu būdu galima susidaryti išsamų vaizdą apie įmonės našumą. Norint geriau įvertinti įmonės raidą, svarbu lyginti AAQS su kitų tos pačios srities įmonių rodikliais. Apibendrinant, investuotojai turėtų visada vertinti įmonės AAQS kontekste su kitais finansiniais rodikliais, tokiomis kaip pelnas, EBIT, pinigų srautai ir kiti, norėdami priimti pagrįstus investicinius sprendimus.

Assura Aktienanalyse

Ką veikia Assura?

Assura PLC is a British healthcare provider that primarily operates in England. The company was formed in 2003 through the merger of two companies, the Mercury Health Group and the Assura Group. Since then, Assura has experienced rapid growth and is now one of the largest healthcare companies in the UK, with an annual turnover of nearly £100 million. Assura PLC's business model is based on a comprehensive approach to healthcare, which includes close collaboration between doctors, specialists, care and health networks, and state-of-the-art medical technology. The goal of Assura is to ensure comprehensive patient care and facilitate effective treatment and quick recovery. Assura offers a wide range of healthcare services to its patients, ranging from general medical care to specialist consultations and the provision of medications and therapeutic measures. Assura PLC's business strategy is focused on expansion and growth. The company is divided into various business areas, including primary care and nursing, as well as telemedicine and technological innovations in healthcare. Through the development of partnerships and joint ventures with other companies, as well as through acquisitions and mergers, Assura has the opportunity to further expand and diversify its service offerings. The main business area of Assura PLC is general medicine. In this area, the company operates doctors' practices and clinics throughout England, where patients have access to a wide range of medical services. The facilities are equipped with state-of-the-art medical equipment and provide friendly and efficient care. Assura has also developed expertise in the field of nursing and operates facilities to realize this broad range of services. Another growing area is telemedicine, which allows patients to receive medical advice and treatment from home. Assura is currently developing innovative technologies to further expand and improve telemedicine, providing its customers with fast and effective medical care. Assura also offers specialized services, such as investigations and treatments for concerns such as oncology. The specialists at Assura are highly qualified doctors with many years of experience and knowledge in their field, ensuring effective treatment and care for patients. The company also has development potential in the area of physical and mental health. They have initiated a growing number of projects and initiatives to improve the well-being of patients, particularly in areas heavily affected by nuances. Assura also specializes in disease prevention and promoting a healthier lifestyle, aiming to support patients in achieving these goals. In terms of product range, Assura PLC offers a wide range of products aimed at promoting and improving health and well-being. They offer various medications and healthcare products, including supplements and vitamins to help patients improve their physical condition. Assura also produces medical devices and diagnostic systems and collaborates with leading manufacturers in the industry to develop innovative technological solutions to transform healthcare. Assura's focus will continue to be on delivering high-quality medical care services. Through the use of cutting-edge technology and a wide range of offerings, the company aims to become a leading provider of healthcare services in the UK. Assura ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Dažniausiai užduodami klausimai apie Assura akciją

Akcijų taupymo planai siūlo patrauklią galimybę investuotojams ilgalaikėje perspektyvoje kurti turtą. Vienas pagrindinių privalumų yra vadinamasis vidutinės išlaidos efektas: reguliariai investuojant fiksuotą sumą į akcijas arba akcijų fondus, automatiškai perkama daugiau dalinių vertybių popierių, kai kainos yra žemos, ir mažiau – kai jos aukštos. Tai gali lemti palankesnę vidutinę dalies kainą per laiką. Be to, akcijų taupymo planai suteikia galimybę ir smulkiesiems investuotojams patekti į brangias akcijas, nes jie gali dalyvauti jau su mažomis sumomis. Reguliarus investavimas taip pat skatina disciplinuotą investavimo strategiją ir padeda išvengti emociškai pagrįstų sprendimų, pavyzdžiui, impulsyvaus pirkimo ar pardavimo. Be to, investuotojai gauna naudos iš potencialaus akcijų vertės augimo bei iš dividendų, kurie gali būti reinvestuoti, kas sustiprina sudėtinio palūkanų efektą ir taip skatina investuoto kapitalo augimą.

Andere Kennzahlen von Assura

Mūsų akcijų analizė Assura Apimtis akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Assura Apimtis. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: